Skip to Main Content

Paper Details

Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant <i>Staphylococcus aureus</i>: A Retrospective Single-Centre Experience.
Antibiotics (Basel)
5
2022
Author NameAffiliation
Maria MazzitelliPadua University Hospital
  • 1 - 1

Datasets

Release 1.2